Prenatal nicotine alters nicotinic receptor development in the mouse brain

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Maternal smoking during pregnancy is linked to adverse child development.
• Mechanisms underlying these effects, particularly on brain development, remain unclear.
• Nicotine exposure in adults alters brain nicotinic receptors and tolerance, influenced by genetic factors.

Purpose of the Study:

• To investigate the impact of prenatal nicotine exposure on the developmental patterns of mouse brain nicotinic receptors.
• To determine if genetic factors influence the response to prenatal nicotine exposure.
• To explore potential mechanisms behind developmental alterations in nicotinic receptor binding.

Main Methods:

• Pregnant mice from two inbred strains (C3H/2ibg and C57BL/6ibg) received chronic subcutaneous nicotine infusion during the latter half of gestation.
• Offspring brains were analyzed for developmental profiles of [3H]nicotine and alpha-[125I]bungarotoxin binding in seven regions.
• Binding assays were conducted at birth and at later developmental stages (20-30 days).

Main Results:

• Prenatal nicotine exposure increased [3H]nicotine binding at birth in specific regions of C3H and C57BL offspring.
• Elevated [3H]nicotine binding persisted at 20-30 days in multiple brain regions for both strains.
• The alpha-[125I]bungarotoxin binding site showed minimal alterations due to prenatal nicotine exposure.
• Upregulated binding returned to control levels within seven days post-cessation, suggesting non-simple upregulation.

Conclusions:

• Prenatal nicotine exposure significantly alters the developmental profile of [3H]nicotine binding sites in the mouse brain.
• Genetic background influences the regional and temporal patterns of these alterations.
• The observed changes suggest complex, potentially long-lasting, neurodevelopmental effects of maternal nicotine exposure, not solely explained by simple receptor upregulation.